Binx
Generated by Meeveem AI
"Rapid molecular diagnostics that enable single visit diagnosis and treatment for STIs."
Cambridge, MA
•51 - 250 Employees
•Diagnostics
About Binx
binx health develops point of care molecular diagnostic solutions that make sexual health testing more accessible. The company's flagship product, binx io, is the first FDA cleared, CLIA waived rapid test for chlamydia and gonorrhea, delivering lab quality results in 30 minutes. This enables clinicians to diagnose and treat patients in a single visit rather than requiring follow up appointments. Founded in 2005 and based in Cambridge, Massachusetts, binx health partners with healthcare providers, public health departments, and community organisations to expand sexual health services. The approach reduces treatment delays and increases access for underserved communities through clinic based testing and at home sample collection programmes.
85
Team Members
2005
Founded
Diagnostics
Sector
On-Site
Work Environment
Our Vision
A future where every person can access high quality diagnostic testing where and when they need it, removing barriers to timely treatment and creating healthier communities through equitable healthcare delivery.
Our Mission
At binx health, our mission is to improve the well being of communities by providing pathways to care that prioritise clinical integrity and patient convenience through innovative diagnostic solutions.